Home
About
FAQ
History (6)
Interleukin 6 (IL6) level is a biomarker for functional disease progression within IL6R358Ala variant groups in amyotrophic lateral sclerosis patients.
Lower complication rates associated with transradial versus transfemoral flow diverting stent placement.
Optimal use of older donors and recipients in kidney transplantation.
Principal Investigator
Infliximab for inpatient psoriasis management--is there a role?
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Infliximab for inpatient psoriasis management--is there a role?
Nelson AA, Pearce DJ, Fleischer AB, Balkrishnan R, Feldman SR. Infliximab for inpatient psoriasis management--is there a role? J Dermatolog Treat. 2005; 16(5-6):314-8.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Dermatologic Agents
Hospital Charges
Hospitalization
Humans
Prescription Fees
Psoriasis
authors with profiles
Steven R. Feldman MD, PhD